Skip to main content
SpringerLink
Log in

Specific Lesion Subsets

  • Chapter
Atlas of Interventional Cardiology

  • 59 Accesses

Abstract

One of the early lessons in interventional cardiology was the discovery that certain angiographic features were associated with poor acute outcome, in particular, abrupt or threatened occlusion [1,2]. Because these lesion characteristics accounted for a major portion of the morbidity related to balloon angioplasty, guidelines were developed in an effort to risk-stratify patients based on angiographic criteria and to dissuade intervention in high-risk subgroups [3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ellis SG, Roubin GS, King SB III, et al.: Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 1988, 77:372–379.

    CAS  PubMed  Google Scholar 

  2. Myler RK, Shaw RE, Stertzer SH, et al.: Lesion morphology and coronary angioplasty: current experience and analysis.J Am Coll Cardiol 1992, 19:1641–1652.

    CAS  PubMed  Google Scholar 

  3. Ryan TJ, Faxon DP, Gunnar RM, et al.: Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Coronary Angioplasty). J Am Coll Cardiol 1988, 12:529–545.

    Google Scholar 

  4. Ellis SG, Guetta V, Miller D, et al.: Relation between lesion characteristics and risk with percutaneous intervention in the stent and glycoprotein IIb /IIIa era: an analysis of results from 10,907 lesions and proposal for new classification scheme. Circulation 1999, 100:1971–1976.

    CAS  PubMed  Google Scholar 

  5. Topol EJ, Ellis SG, Fishman J, et al.: Multicenter study of percutaneous transluminal angioplasty for right coronary artery ostial stenosis.J Am Coll Cardiol 1987, 9:1214–1218.

    CAS  PubMed  Google Scholar 

  6. Sabri MN, Cowley MJ, DiSciascio G, et al.: Immediate results of interventional devices for coronary ostial narrowing with angina pectoris. Am J Cardiol 1994, 73:122–125.

    CAS  PubMed  Google Scholar 

  7. Jain SP, Liu MW, Dean LS, et al.: Comparison of balloon angioplasty versus debulking devices versus stenting in right coronary ostial lesions. Am J Cardiol 1997, 79:1334–1338.

    CAS  PubMed  Google Scholar 

  8. Motwani JG, Raymond RE, Franco I, et al.: Effectiveness of rotational atherectomy of right coronary artery ostial stenosis. Am J Cardiol 2000, 85:563–567.

    CAS  PubMed  Google Scholar 

  9. Rocha-Singh K, Morris N, Wong SC, et al.: Coronary stenting for treatment of ostial stenoses of native coronary arteries or aortocoronary saphenous venous grafts. Am J Cardiol 1995, 75:26–29.

    CAS  PubMed  Google Scholar 

  10. Silvestri M, Barragan P, Sainsous J, et al.: Unprotected left main coronary artery stenting: immediate and medium-term outcomes of 140 elective procedures. J Am Coll Cardiol 2000, 35:1543–1550.

    CAS  PubMed  Google Scholar 

  11. Amin FR, Horlitz M, Yousufuddin M, et al.: Acute and long-term clinical outcome of aorto-ostial vs non-aorto-ostial stenting. Am J Cardiol 2000; TCT abstracts:43i.

    Google Scholar 

  12. Rieu R, Barragan P, Masson C, et al.: Radial force of coronary stents: a comparative analysis. Cathet Cardiovasc Intervent 1999, 46:380–391.

    CAS  Google Scholar 

  13. Mathias DW, Mooney JF, Lange HW, et al.: Frequency of success and complications of coronary angioplasty of a stenosis at the ostium of a branch vessel. Am J Cardiol 1991, 67:491–495.

    CAS  PubMed  Google Scholar 

  14. Tan KH, Sulke N, Taub N, Sowton E: Percutaneous transluminal coronary angioplasty of aorta ostial, non-aorta ostial, and branch ostial stenoses: acute and long-term outcome. Eur Heart J 1995, 16:631–639.

    CAS  PubMed  Google Scholar 

  15. Al Suwaidi J, Berger PB, Rihal CS, et al.: Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions.J Am Coll Cardiol 2000, 35:929–936.

    CAS  PubMed  Google Scholar 

  16. Peacock J, Jones T, Tock C, et al.: An in vitro study on the effect of branch points on the stability of coronary artery flow. Med Eng Phys 1997, 19:101–108.

    CAS  PubMed  Google Scholar 

  17. Perktold K, Hofer M, Rappitsch G, et al.: Validated computation of physiologic flow in a realistic coronary artery branch.J Biomech 1998, 31:217–228.

    CAS  PubMed  Google Scholar 

  18. Brener SJ, Leya FS, Apperson-Hanson C, et al.: A comparison of debulking versus dilatation of bifurcation coronary arterial narrowings (from the CAVEAT I trial). Am J Cardiol 1996, 78:1039–1041.

    CAS  PubMed  Google Scholar 

  19. Dauerman HL, Higgins PJ, Sparano AM, et al.: Mechanical debulking versus balloon angioplasty for the treatment of true bifurcation lesions.J Am Coll Cardiol 1998, 32:1845–1852.

    CAS  PubMed  Google Scholar 

  20. Rihal CS, Garratt KN, Holmes DR: Rotational atherectomy for bifurcation lesions of the coronary circulation: technical and initial experience. Int J Cardiol 1998, 65:1–9.

    CAS  PubMed  Google Scholar 

  21. Oesterle SN: Coronary interventions at a crossroads: the bifurcation stenosis. J Am Coll Cardiol 1998, 32:1853–1854.

    CAS  PubMed  Google Scholar 

  22. Pan M, Medina A, Suarez de Lezo J, et al.: Follow-up patency of side branches covered by intracoronary Palmaz-Schatz stent. Am Heart J 1995, 129:436–440.

    CAS  PubMed  Google Scholar 

  23. Fischman DL, Savage MP, Leon MB, et al.: Rate of lesion-related side branches after coronary artery stenting. J Am Coll Cardiol 1993, 22:1641–1646.

    CAS  PubMed  Google Scholar 

  24. Ellis SG, Lincoff AM, Miller D, et al.: Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. J Am Coll Cardiol 1998, 32:1619–1623.

    CAS  PubMed  Google Scholar 

  25. Arora RR, Raymond RE, Dimas AP, et al.: Side branch occlusion during coronary angioplasty: incidence, angiographic characteristics, and outcome. Cathet Cardiovasc Diagn 1989, 18:210–212.

    CAS  PubMed  Google Scholar 

  26. Stone GW, Rutherford BD, McConahay DR, et al.: Procedural outcome of angioplasty for total coronary artery occlusion: an analysis of 971 lesions in 905 patients. J Am Coll Cardiol 1990, 15:849–856.

    CAS  PubMed  Google Scholar 

  27. Ivanhoe RJ, Weintraub WS, Douglas JS Jr, et al.: Percutaneous transluminal coronary angioplasty of chronic total occlusions. Circulation 1992, 85:106–115.

    CAS  PubMed  Google Scholar 

  28. Bell MR, Berger PB, Bresnahan JF, et al.: Initial and long term outcome of 354 patients following coronary balloon angioplasty of total coronary artery occlusions. Circulation 1992, 85:1003–1011.

    CAS  PubMed  Google Scholar 

  29. Ruocco NA, Ring ME, Holubkov R, et al.: Results of coronary angioplasty of chronic total occlusions (the National Heart, Lung, and Blood Institute 1985–1986 Percutaneous Transluminal Angioplasty Registry). Am J Coll Cardiol 1992, 69:69–76.

    Google Scholar 

  30. Haine E, Urban P, Dorsaz PA, Meier B: Outcome and complications of 500 consecutive chronic total occlusion angioplasties.J Am Coll Cardiol 1993, 2L138A.

    Google Scholar 

  31. Kinoshita I, Katoh O, Nariyama J, et al.: Coronary angioplasty of chronic total occlusions with bridging collateral vessels: immediate and follow-up outcome from a large single-center experience.J Am Coll Cardiol 1995, 26:409–415.

    CAS  PubMed  Google Scholar 

  32. Noguchi T, Miyazaki S, Morii I, et al.: Percutaneous transluminal coronary angioplasty of chronic total occlusions. Determinants of primary success and long-term clinical outcome. Cathet Cardiovasc Interv 2000, 49:258–264.

    CAS  Google Scholar 

  33. Serruys PW, Hamburger JN, Koolen JJ, et al.: Total occlusion trial with angioplasty by using laser guidewire. The TOTAL trial. Eur Heart J 2000, 21:1737–1738.

    Google Scholar 

  34. Koolen JJ, Bonnier H, Grube E: A novel guiding system for facilitating the crossing of plaque and chronic total occlusions (abstract).J Am Coll Cardiol 2000, 35:40A.

    Google Scholar 

  35. Braden GA, Xenopoulos NP, Young T, et al.: Transluminal extraction catheter atherectomy followed by immediate stenting in treatment of saphenous vein grafts. J Am Coll Cardiol 1997, 30:657–663.

    CAS  PubMed  Google Scholar 

  36. Waksman R, Weintraub WS, Ghazzal Z, et al.: Short- and long-term outcome of narrowed saphenous vein bypass graft: a comparison of Palmaz-Schatz stent, directional coronary atherectomy, and balloon angioplasty Am Heart J 1997, 134:274–281.

    CAS  PubMed  Google Scholar 

  37. Buller CE, Dzavik V, Carere RG, et al.: Primary stenting versus balloon angioplasty in occluded coronary arteries: the total occlusion study of Canada (TOSCA). Circulation 1999, 100:236–242.

    CAS  PubMed  Google Scholar 

  38. Hoher M, Wohrle J, Grebe OC, et al.: A randomized trial of elective stenting after balloon recanalization of chronic total occlusions.J Am Coll Cardiol 1999, 34:722–729.

    CAS  PubMed  Google Scholar 

  39. Lotan C, Rozenman Y, Hendler A, et al.: Stents in total occlusion for restenosis prevention. The Multicentre randomized STOP study. The Israeli Working Group for Interventional Cardiology. Eur Heart J 2000, 21:1960–1966.

    CAS  PubMed  Google Scholar 

  40. Hamburger JN, Serruys PW: The battle of Vladimir. Eur Heart J 2000, 21:1911–1913.

    CAS  PubMed  Google Scholar 

  41. Katsuragawa M, Fujiwara H, Miyamae M, et al.: Histologic studies in percutaneous transluminal coronary angioplasty for chronic total occlusion: comparison of tapering and abrupt types of occlusion and short and long occluded segments. J Am Coll Cardiol 1993, 21:604–611.

    CAS  PubMed  Google Scholar 

  42. Berger PB, Bresnahan J: Use of excimer laser in the treatment of chronic total occlusion of a coronary artery that cannot be crossed with a balloon catheter. Cathet Cardiovasc Diagn 1993, 28:44–46.

    CAS  PubMed  Google Scholar 

  43. Fitzgerald PJ, Ports TA, Yock PG: Contribution of localized calcium deposits to dissection after angioplasty: an observational study using intravascular ultrasound. Circulation 1992, 86:64–70.

    CAS  PubMed  Google Scholar 

  44. Komiyama N, Stone GW, Alderman EL, et al.: Relative stent expansion is dependent upon target segment calcification: an intravascular ultrasound assessment. Circulation 1996, 94 (suppl I):I—262.

    Google Scholar 

  45. Mintz GS, Popma JJ, Pichard AD, et al.: Patterns of calcification in coronary artery disease: a statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions. Circulation l995, 91:1959–1965.

    CAS  PubMed  Google Scholar 

  46. Moussa I, Di Mario C, Moses J, et al.: Coronary stenting after rotational atherectomy in calcified and complex lesions: angiographic and clinical follow-up results. Circulation 1997, 96:128–136.

    CAS  PubMed  Google Scholar 

  47. Henneke KH, Regar E, Konig A, et al.: Impact of target lesion calcification on coronary stent expansion after rotational atherectomy. Am Heart J 1999, 137:93–99.

    CAS  PubMed  Google Scholar 

  48. Hoffmann R, Mintz GS, Kent KM, et al.: Is there an optimal therapy for calcified lesions in large vessels? Comparative acute and follow-up results of rotational atherectomy, stents, or the combination.J Am Coll Cardiol 1997, 29:68A.

    Google Scholar 

  49. Ryan TJ, Bauman WB, Kennedy JW, et al.: Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/ American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1996, 88:2987–3007.

    Google Scholar 

  50. Savage MP, Goldberg S, Hirshfeld JW, et al.: Clinical and angiographic determinants of primary coronary angioplasty success.J Am Coll Cardiol 1991, 17:22–28.

    CAS  PubMed  Google Scholar 

  51. Schunkert H, Harreil L, Palacious IF: Implications of small reference vessel diameter in patients undergoing percutaneous coronary revascularization. J Am Coll Cardiol 1999, 34:40–48.

    CAS  PubMed  Google Scholar 

  52. Hirshfeld JW, Schwartz JS, Jugo R, et al.: Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. The M-HEART Investigators.J Am Coll Cardiol 1991, 18:647–656.

    PubMed  Google Scholar 

  53. Foley DP, Melkert R, Serruys PW: Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty Circulation 1994, 90:1239–1251.

    CAS  PubMed  Google Scholar 

  54. Savage MP, Fischman DL, Rake R, et al.: Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries: Stent Restenosis Study (STRESS) Investigators.J Am Coll Cardiol 1998, 31:307–311.

    CAS  PubMed  Google Scholar 

  55. Elezi S, Kastrati A, Neumann FJ, et al.: Vessel size and long-term outcome after coronary stent placement. Circulation 1998, 98:1875–1880.

    CAS  PubMed  Google Scholar 

  56. Briguori C, Nishida T, Adamian M, et al.: Coronary stenting versus balloon angioplasty in small coronary artery with complex lesions. Cathet Cardiovasc Mew 2000, 50:390–397.

    CAS  Google Scholar 

  57. Kastrati A, Schomig A, Dirschinger J, et al.: A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease. ISAR-SMART Study Investigators. Intracoronary stenting or angioplasty for restenosis reduction in small arteries. Circulation 2000, 102(21):2593–2598.

    CAS  PubMed  Google Scholar 

  58. Sigwart U, Prasad S, Radke P, Nadra I: Stent coatings.J Invasive Cardiol 2001, 13(2):141–142, discussion 158–170.

    CAS  PubMed  Google Scholar 

  59. Goudreau E, DiSciascio G, Kelly K, et al.: Coronary angioplasty of diffuse coronary artery disease. Am Heart J 1991, 121(1 pt 1):12–19.

    CAS  PubMed  Google Scholar 

  60. Bergelson BA, Jacobs AK, Cupples LA, et al.: Prediction of risk for hemodynamic compromise during percutaneous transluminal coronary angioplasty. Am J Cardiol 1992, 70(20):1540–1545.

    CAS  PubMed  Google Scholar 

  61. de Feyter PJ, de Jaegere PP, Serruys PW: Incidence, predictors, and management of acute coronary occlusion after coronary angioplasty. Am Heart J 1994, 127(3):643–651.

    PubMed  Google Scholar 

  62. Kaul U, Upasani PT, Agarwal R, et al.: In-hospital outcome of percutaneous transluminal coronary angioplasty for long lesions and diffuse coronary artery disease. Cathet Cardiovasc Diagn 1995, 35(4):294–300.

    CAS  PubMed  Google Scholar 

  63. Cannon AD, Roubin GS, Hearn JA, et al.: Acute angiographic and clinical results of long balloon percutaneous transluminal coronary angioplasty and adjuvant stenting for long narrowings. Am J Cardiol 1994, 73(9):635–641.

    CAS  PubMed  Google Scholar 

  64. Di Sciascio G, Patti G, Nasso G, et al.: Early and long-term results of stenting diffuse coronary artery disease. Am J Cardiol 2000, 86(11):1166–1170.

    PubMed  Google Scholar 

  65. Kobayashi Y, DeGregorio J, Kobayashi N, et al.: Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol 1999, 34(3):651–659.

    CAS  PubMed  Google Scholar 

  66. Kastrati A, Elezi S, Dirschinger J, et al.: Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol 1999, 83:1617–1622.

    CAS  PubMed  Google Scholar 

  67. Bauters C, Hubert E, Prat A, et al.: Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol 1998, 31:1291–1298.

    CAS  PubMed  Google Scholar 

  68. Kornowski R, Mehran R, Hong MK, et al.: Procedural results and late clinical outcomes after placement of three or more stents in single coronary lesions. Circulation 1998, 97:1355–1361.

    CAS  PubMed  Google Scholar 

  69. Liu MW, Luo JF, Dean LS, et al.: Long-term follow-up study of coronary reconstruction with multiple stents. Am Heart J 1999, 137:292–297.

    CAS  PubMed  Google Scholar 

  70. Rozenman Y, Mereuta A, Schechter D, et al.: Long-term outcome of patients with very long stents for treatment of diffuse coronary disease. Am Heart J 1999, 138:441–445.

    CAS  PubMed  Google Scholar 

  71. DeGregorio J, Moussa I, Adamian M, et al.: The use of IVUS-guided PTCA and spot stenting for the treatment of long lesions: a comparison to traditional stenting. J Am Coll Cardiol 2000; abstracts-ACCIS 2000:62A.

    Google Scholar 

  72. White CJ, Ramee SR, Collins TJ, et al.: Coronary thrombi increase PTCA risk. Angioscopy as a clinical tool. Circulation 1996, 93:253–258.

    CAS  PubMed  Google Scholar 

  73. Vaitkus PT, Hermann HC, Laskey W: Management and immediate outcome of patients with intracoronary thrombus during percutaneous transluminal coronary angioplasty. Am Heart J 1992, 124:1–8.

    CAS  PubMed  Google Scholar 

  74. Block PB, Peterson EC, Krone R, et al.: Identification of variables needed to risk-adjust outcomes of coronary interventions: evidence-based guidelines for efficient data collection.J Am Coll Cardiol 1998, 32:275–282.

    CAS  PubMed  Google Scholar 

  75. den Heijer P, Foley DP, Escaned J, et al.: Angioscopic versus angiographic detection of intimai dissection and intracoronary thrombus.J Am Coll Cardiol 1994, 24:649–654.

    Google Scholar 

  76. Cohen M, Demers C, Gurfinkel EP, et al.: A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 1997, 337:447–452.

    CAS  PubMed  Google Scholar 

  77. Wallentin L: Low-molecular-weight heparins in coronary thrombosis: today and tomorrow. Haemostasis 1999, 29(suppl Sl):32–37.

    CAS  PubMed  Google Scholar 

  78. Topol EJ: Evolution of improved antithrombotic and antiplatelet agents: genesis of the Comparison of Abciximab Complications with Hirulog [and Back-up Abciximab] Events Trial (CACHET). Am J Cardiol 1998, 82(8B):63P-68P.

    Google Scholar 

  79. Mehta SR, Yusuf S, Peters RJG, et al.: Effects of pretreatment with Clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001, 358:9281.

    Google Scholar 

  80. Cannon CP, Weintraub WS, Demopoulos LA, et al.: Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001, 344:1879–1887.

    CAS  PubMed  Google Scholar 

  81. Mehran R, Ambrose JA, Bongu RM, et al.: Angioplasty of complex lesions in ischemic rest angina: results of the Thrombolysis and Angioplasty in Unstable Angina (TAUSA) trial. J Am Coll Cardiol 1995, 26:961–966.

    CAS  PubMed  Google Scholar 

  82. Gold HK, Garabedian HD, Dinsmore RE, et al.: Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators. Observations in animals and humans. Circulation 1997, 95:1755–1759.

    CAS  PubMed  Google Scholar 

  83. Muhlestein JB, Karagounis LA, Treehan S, et al.: “Rescue” utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty.J Am Coll Cardiol 1997, 30:1729–1734.

    CAS  PubMed  Google Scholar 

  84. Mak KH, Challapalli R, Eisenberg MJ, et al.: Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. Am J Cardiol 1997, 80:985–988.

    CAS  PubMed  Google Scholar 

  85. Ellis SG, Lincoff LM, Miller D, et al.: Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology: EPIC and EPILOG investigators.J Am Coll Cardiol 1998, 32:1619–1623.

    CAS  PubMed  Google Scholar 

  86. Mathew V, Grill DE, Scott CG, et al.: The influence of abciximab use on clinical outcome after aortocoronary vein graft interventions.J Am Coll Cardiol 1999, 34:1163–1169.

    CAS  PubMed  Google Scholar 

  87. Barsness GW, Buller C, Ohman EM, et al.: Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein grafts. Am Heart J 2000, 139:824–829.

    CAS  PubMed  Google Scholar 

  88. The PURSUIT Trial Investigators: Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrum Therapy. N Engl J Med 1998, 339:436–443.

    Google Scholar 

  89. O’Shea JC, Hafley GE, Greenberg S, et al.: Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial. JAMA 2001, 285:2468–2473.

    PubMed  Google Scholar 

  90. PRISM-PLUS Study Investigators: Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q wave myocardial infarction. N Engl J Med 1998, 338:1488–1497.

    Google Scholar 

  91. Bhatt DL, Topol EJ: Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. JAMA 2000, 284:1549–1558.

    CAS  PubMed  Google Scholar 

  92. Bailey SR, O’Leary E, Chilton R: Angioscopic evaluation of site-specific administration of ReoPro. Cathet Cardiovasc Diagn 1997, 42:181–184.

    CAS  PubMed  Google Scholar 

  93. Kiesz RS, Buszman P, Martin JL, et al.: Local delivery of enoxaparin to decrease restenosis after stenting: results of initial multicenter trial: Polish-American Local Lovenox NIR Assessment study (The POLONIA study). Circulation 2001, 103:26–31.

    CAS  PubMed  Google Scholar 

  94. Mitchel JF, Fram DB, Palme DF II, et al.: Enhanced intracoronary thrombolysis with urokinase using a novel, local delivery system: in vitro, in vivo, and clinical studies. Circulation 1995, 91:785–793.

    CAS  PubMed  Google Scholar 

  95. Fram DB, Mitchel JF, Asrin MA, et al.: Local delivery of heparin to balloon angioplasty sites with a new angiotherapy catheter: pharmacokinetics and effect on platelet deposition in the porcine model. Cathet Cardiovasc Diagn 1997,41:275–286.

    CAS  PubMed  Google Scholar 

  96. Silva JA, Ramee SR: The emergence of mechanical thrombectomy; a clot burden reduction approach. Semin Interv Cardiol 2000, 5:137–147.

    CAS  PubMed  Google Scholar 

  97. Wheisenant BK, Bairn DS, Kuntz RE, et al.: Rheolytic thrombectomy with the Possis AngioJet? Technical considerations and initial clinical experience. J Invasive Cardiol 1999, 11:421–426.

    Google Scholar 

  98. Silva JA, Ramee SR, Cohen DJ, et al.: Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: experience with the Angiojet catheter. Am Heart J 2001, 141:353–359.

    CAS  PubMed  Google Scholar 

  99. Rosenschein U, Roth A, Rassin T, et al.: Analysis of coronary ultrasound thrombolysis endpoints in acute myocardial infarction (ACUTE trial): results of the feasibility study. Circulation 1997, 95:1411–1416.

    CAS  PubMed  Google Scholar 

  100. Safian RD, May MA, Lichtenberg A, et al.: Detailed clinical and angiographic analysis of transluminal extraction coronary atherectomy for complex lesions in native coronary arteries.J Am Coll Cardiol 1995, 25:848–854.

    CAS  PubMed  Google Scholar 

  101. Stone GW: X-sizer for treatment of thrombus and atherosclerosis in coronary interventions trial (X-TRACT) results. Presented at TCT, October 2002, Washington, DC.

    Google Scholar 

  102. Hong MK, Popma JJ, Pichard AD, et al.: Clinical significance of distal embolization after transluminal extraction atherectomy in diffusely diseased saphenous vein grafts. Am Heart J 1994, 127:1496–1503.

    CAS  PubMed  Google Scholar 

  103. Holmes DR Jr, Topol EJ, Califf RM, et al.: A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions: CAVEAT-II Investigators. Circulation 1995,91:1966–1974.

    PubMed  Google Scholar 

  104. Hong MK, Mehran R, Dangas G, et al.: Creatinine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 1999, 100(24):2400–2405.

    CAS  PubMed  Google Scholar 

  105. Campeau L, Lesperance J, Hermann J, et al.: Loss of the improvement of angina between 1 and 7 years after aortocoronary bypass surgery: correlations with changes in vein grafts and in coronary arteries. Circulation 1979, 60(2 pt 2):l-5.

    Google Scholar 

  106. Bourassa MG, Enjalbert M, Campeau L, et al.: Progression of coronary artery disease between 10 and 12 years after coronary artery bypass graft surgery. In Prognosis of Coronary Heart Disease: Progression of Coronary Arteriosclerosis. Edited by Roskamm H. Berlin: Springer-Verlag; 1983:150.

    Google Scholar 

  107. Frick MH, Valle M, Harjola PT: Progression of coronary artery disease in randomized medical and surgical patients over a 5-year angiographic follow-up. Am J Cardiol 1983, 52:681.

    CAS  PubMed  Google Scholar 

  108. Hwang MH, Meadows WR, Palac RT, et al.: Progression of native coronary artery disease at 10 years: insights from a randomized study of medical versus surgical therapy for angina. J Am Coll Cardiol 1990, 16:1066–1070.

    CAS  PubMed  Google Scholar 

  109. 108.Corbelli J, Franco I, Hollman J, et al.: Percutaneous transluminal coronary angioplasty after previous coronary artery bypass surgery. Am J Cardiol 1985, 56:398–403.

    PubMed  Google Scholar 

  110. Douglas JS Jr, Gruentzig AR, King SB III, et al.: Percutaneous transluminal coronary angioplasty in patients with prior coronary bypass surgery. J Am Coll Cardiol 1983, 2:745–754.

    PubMed  Google Scholar 

  111. Ernst SM, van der Feltz TA, Ascoop CA, et al.: Percutaneous transluminal coronary angioplasty in patients with prior coronary artery bypass grafting. Long-term results.J Thorac Cardiovasc Surg 1987, 93:268–275.

    CAS  PubMed  Google Scholar 

  112. Mathew V, Clavell AL, Lennon RJ, et al.: Percutaneous coronary interventions in patients with prior coronary artery bypass surgery: changes in patient characteristics and outcome during two decades. Am J Med 2000, 108:127–135.

    CAS  PubMed  Google Scholar 

  113. Morrison DA, Crowley ST, Veerakul G, et al.: Percutaneous transluminal angioplasty of saphenous vein grafts for medically refractory unstable angina. J Am Coll Cardiol 1994, 23:1066–1070.

    CAS  PubMed  Google Scholar 

  114. Stephan WJ, O’Keefe JH Jr, Piehler JM, et al.: Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery. J Am Coll Cardiol 1996, 28:1140–1146.

    CAS  PubMed  Google Scholar 

  115. Gruberg L, Hong MK, Mehran R, et al.: In-hospital and long-term results of stent deployment compared with balloon angioplasty for treatment of narrowing at the saphenous vein graft distal anastomosis site. Am J Cardiol 1999, 84:1381–1384.

    CAS  PubMed  Google Scholar 

  116. Plokker HW, Meester BH, Serruys PW: The Dutch experience in percutaneous transluminal angioplasty of narrowed saphenous veins used for aortocoronary arterial bypass. Am J Cardiol 1991, 67(5):361–366.

    CAS  PubMed  Google Scholar 

  117. Pomerantz RM, Kuntz RE, Carrozza JP, et al.: Acute and long-term outcome of narrowed saphenous venous grafts treated by endoluminal stenting and directional atherectomy. Am J Cardiol 1992, 70:161–167.

    CAS  PubMed  Google Scholar 

  118. Waksman R, Popma JJ, Kennard ED, et al.: Directional coronary atherectomy (DCA): A report from the new approaches to coronary intervention (NACI) registry. Am J Cardiol 1997, 80(10A):50K-59K.

    Google Scholar 

  119. Waksman R, Weintraub WS, Ghazzal Z, et al.: Short- and long-term outcome of narrowed saphenous vein bypass graft: a comparison of Palmaz-Schatz stent, directional coronary atherectomy, and balloon angioplasty. Am Heart J 1997, 134(2 Pt 1):274–81.

    CAS  PubMed  Google Scholar 

  120. Braden GA, Xenopoulos NP, Young T, et al.: Transluminal extraction catheter atherectomy followed by immediate stenting in treatment of saphenous vein grafts. J Am Coll Cardiol 1997, 30(3):657–663.

    CAS  PubMed  Google Scholar 

  121. Dooris M, Hoffmann M, Glazier S, et al.: Comparative results of transluminal extraction coronary atherectomy in saphenous vein graft lesions with and without thrombus. J Am Coll Cardiol 1995, 25(7):1700–1705.

    CAS  PubMed  Google Scholar 

  122. Meany TB, Leon MB, Kramer BL, et al.: Transluminal extraction catheter for the treatment of diseased saphenous vein grafts: a multicenter experience. Cathet Cardiovasc Diagn 1995, 34:112–120.

    CAS  PubMed  Google Scholar 

  123. Misumi K, Matthews RV, Sun GW, et al.: Reduced distal embolization with transluminal extraction atherectomy compared to balloon angioplasty for saphenous vein graft disease. Cathet Cardiovasc Diagn 1996, 39:246–251.

    CAS  PubMed  Google Scholar 

  124. Moses JW, Maussa I, Popma JJ, et al.: Risk of distal embolization and infarction with transluminal extraction atherectomy in saphenous vein grafts and native coronary arteries. Catheter Cardiovasc Interv 1999, 47:149–154.

    CAS  PubMed  Google Scholar 

  125. 124.Safian RD, Grines CL, May MA, et al.: Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts. Circulation 1994, 89:302–312.

    CAS  PubMed  Google Scholar 

  126. Sketch MH, Davidson CJ, Yeh W, et al.: Predictors of acute and long-term outcome with transluminal extraction atherectomy: the new approaches to coronary intervention (NACI) registry. Am J Cardiol 1997, 80(10A):68K-77K.

    Google Scholar 

  127. Bittl JA, Sanborn TA, Yardley DE, et al.: Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions. Am J Cardiol 1994, 74:144–148.

    CAS  PubMed  Google Scholar 

  128. Natarajan MK, Bowman KA, Chisholm RJ, et al.: Excimer laser angioplasty vs. balloon angioplasty in saphenous vein bypass grafts: quantitative angiographic comparison of matched lesions. Cathet Cardiovasc Diagn 1996, 38:153–158.

    CAS  PubMed  Google Scholar 

  129. Strauss BH, Natarajan MK, Batchelor WB, et al.: Early and late quantitative angiographic results of vein graft lesions treated by excimer laser with adjunctive balloon angioplasty. Circulation 1995, 92:348–356.

    CAS  PubMed  Google Scholar 

  130. Savage MP, Douglas JS Jr, Fischman DL, et al.: Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts: Saphenous Vein De Novo Trial Investigators. N Engl J Med 1997, 337:740–747.

    CAS  PubMed  Google Scholar 

  131. Bhargava B, Kornowski R, Mehran R, et al.: Procedural results and intermediate clinical outcomes after multiple saphenous vein graft stenting. J Am Coll Cardiol 2000, 35(2):389–397.

    CAS  PubMed  Google Scholar 

  132. Brener SJ, Ellis SG, Apperson-Hansen C, et al.: Comparison of stenting and balloon angioplasty for narrowings in aortocoronary saphenous vein conduits in place for more than five years. Am J Cardiol 1997, 79(1):13–18.

    CAS  PubMed  Google Scholar 

  133. 132.Fenton SH, Fischman DL, Savage MP, et al.: Long-term angiographic and clinical outcome after implantation of balloon-expandable stents in aortocoronary saphenous vein grafts. Am J Cardiol 1994, 74:1187–1191.

    CAS  PubMed  Google Scholar 

  134. 133.Frimerman A, Rechavia E, Eigler N, et al.: Long-term follow-up of a high risk cohort after stent implantation in saphenous vein grafts.J Am Coll Cardiol 1997, 30(5):1277–1283.

    PubMed  Google Scholar 

  135. Herz I, Assali A, Adler Y, et al.: Coronary stent deployment without predilation: prevention of complications of venous graft angioplasty. Angiology 1998, 49(8):613–617.

    CAS  PubMed  Google Scholar 

  136. Hong MK, Mehran R, Dangas G, et al.: Are we making progress with percutaneous saphenous vein graft treatment? J Am Coll Cardiol 2001, 38:150–154.

    CAS  PubMed  Google Scholar 

  137. Kornowski R, Mehran R, Hong MK, et al.: Procedural results and late clinical outcomes after placement of three or more stents in single coronary lesions. Circulation 1998, 97(14):1355–1361.

    CAS  PubMed  Google Scholar 

  138. Le May MR, Labinaz M, Marquis JF, et al.: Predictors of long-term outcome after stent implantation in a saphenous vein graft. Am J Cardiol 1999, 83(5):681–686.

    PubMed  Google Scholar 

  139. Maiello L, Colombo A, Gianrossi R, et al.: Favourable results of treatment of narrowed saphenous vein grafts with Palmaz-Schatz stent implantation. Eur Heart J 1994, 15:1212–1216.

    CAS  PubMed  Google Scholar 

  140. Keeley EC, Velez CA, O’Neill WW, et al.: Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts.J Am Coll Cardiol 2001, 38:659–665.

    CAS  PubMed  Google Scholar 

  141. Wong SC, Bairn DS, Schatz RA, et al.: Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter U.S. Palmaz-Schatz stent experience. The Palmaz-Schatz Stent Study Group. J Am Coll Cardiol 1995, 26:704–712.

    CAS  PubMed  Google Scholar 

  142. Foley DP, Wijns W, Suryapranata H, et al.: Bypass graft angioplasty using the self-expanding, less-shortening Wallstent — results of the Wallstent CABG study. Eur Heart J 1997, 18(Suppl):157.

    Google Scholar 

  143. Safian RD, Kaplan B, Schreiber T, et al.: Interim results of the Wallstent endoprosthesis in saphenous vein graft trial (WINS). Circulation 1998, (Suppl I) 98:1–662.

    Google Scholar 

  144. Strauss BH, Serruys PW, Bertrand ME, et al.: Quantitative angiographic follow-up of the coronary Wallstent in native vessels and bypass grafts (European experience-March 1986 to March 1990). Am J Cardiol 1992, 69:475–481.

    CAS  PubMed  Google Scholar 

  145. von Birgelen C, Airiian SG, de Feyter PJ, et al.: Coronary Wallstents show significant late, postprocedural expansion despite implantation with adjunct high-pressure balloon inflations. Am J Cardiol 1998, 82(2):129–134.

    Google Scholar 

  146. Caputo RP, Amin N, Marvasti M, et al.: Successful treatment of asaphenous vein graft perforation with an autologous vein-covered stent. Catheter Cardiovasc Interv 1999, 48(4):382–386.

    CAS  PubMed  Google Scholar 

  147. Wong SC, Kent KM, Mintz GS, et al.: Percutaneous transcatheter repair of a coronary aneurysm using a composite autologous cephalic vein-coated Palmaz-Schatz biliary stent. Am J Cardiol 1995, 76:990–991.

    CAS  PubMed  Google Scholar 

  148. Di Mario C, Inglese L, Colombo A: Treatment of a coronary aneurysm with a new polytetrafluoroethylene-coated stent: a case report. Cathet Cardiovasc Intervent 1999, 46:463–465.

    Google Scholar 

  149. Haager PK, Dechene A, Radke PW, et al.: Acute and long-term results with an endoluminal polytetrafluoroethylene stent graft in patients with in-stent restenosis and venous coronary artery bypass grafts. Circulation 1999, (Suppl I), 100(18):1–294.

    Google Scholar 

  150. Baldus S, Koster R, Eisner M, et al.: Treatment of aortocoronary vein graft lesions with membrane covered stents: a multicenter surveillance trial. Circulation 2000, 201:2024–2027.

    Google Scholar 

  151. Silva JA, White CJ, Collins TJ, Ramee SR: Morphologic comparison of atherosclerotic lesions in native coronary arteries and saphenous vein grafts with intracoronary angioscopy in patients with unstable angina. Am Heart J 1998, 136:156–163.

    CAS  PubMed  Google Scholar 

  152. Bourassa MG, Fisher LD, Campeau L, et al.: Long-term fate of bypass grafts: the coronary artery surgery study (CASS) and Montreal Heart Institute experiences. Circulation 1985, 72(Pt 2):V71-V78.

    Google Scholar 

  153. Fernandez-Ortiz A, Badimon JJ, Falk E, et al.: Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 1994, 23:1562–1569.

    CAS  PubMed  Google Scholar 

  154. Webb JG, Myler RK, Shaw RE, et al.: Coronary angioplasty after coronary bypass surgery: initial results and late outcome in 422 patients.J Am Coll Cardiol 1990, 16:812–820.

    CAS  PubMed  Google Scholar 

  155. Lefkovits J, Holmes DR, Califf RM, et al.: Predictors and sequelae of distal embolization during saphenous vein graft intervention from the CAVEAT-II trial: Coronary Angioplasty Versus Excisional Atherectomy Trial. Circulation 1995, 92:734–740.

    CAS  PubMed  Google Scholar 

  156. Webb JG, Carere RG, Virmani R, et al.: Retrieval and analysis of particulate debris after saphenous vein graft intervention.J Am Coll Cardiol 1999, 34(2):468–475.

    CAS  PubMed  Google Scholar 

  157. Teirstein PS, Mann JT, Cundey PE Jr, et al.: Low- versus high-dose recombinant urokinase for the treatment of chronic saphenous vein graft occlusion. Am J Cardiol 1999, 83(12):1623–1628.

    CAS  PubMed  Google Scholar 

  158. Carlino M, DeGregorio J, DiMario C, et al.: Prevention of distal embolization during saphenous vein graft lesion angioplasty: experience with a new temporary occlusion and aspiration system. Circulation 1999, 99(25):3221–3223.

    CAS  PubMed  Google Scholar 

  159. Bairn DS, Wahr D, George B, et al.: Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aortocoronary bypass grafts. Circulation 2002, 105:1285–1290.

    Google Scholar 

  160. Ohki T, Roubin GS, Vieth FJ, et al.: Efficacy of a filter device in the prevention of embolic events during carotid angioplasty and stenting: an ex-vivo analysis.J Vasc Surg 1999, 30:1034–1044.

    CAS  PubMed  Google Scholar 

  161. Glazier JJ, Bauer HH, Kiernan FJ, et al.: Recanalization of totally occluded saphenous vein grafts using local urokinase delivery with the dispatch catheter. Cathet Cardiovasc Diagn 1995, 36:326–332.

    CAS  PubMed  Google Scholar 

  162. Hartmann JR, McKeever LS, O’Neill WW, et al.: Recanalization of chronically occluded aortocoronary saphenous vein bypass grafts with long-term, low dose direct infusion of urokinase (ROBUST): a serial trial.J Am Coll Cardiol 1996, 27:60–66.

    CAS  PubMed  Google Scholar 

  163. Holmes DR Jr, Berger P: Percutaneous revascularization of occluded vein grafts: Is it still a temptation to be resisted? Circulation 1999, 99:8–11.

    PubMed  Google Scholar 

  164. Rosenschein U, Gaul G, Erbel R, et al.: Percutaneous transluminal therapy of occluded saphenous vein grafts: Can the challenge be met with ultrasound thrombolysis? Circulation 1999, 99(l):26–29.

    CAS  PubMed  Google Scholar 

Download references

Authors
  1. Gregory W. Barsness
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John F. Bresnahan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cardiac Catheterization Laboratory, Division of Cardiovascular Diseases, Mayo Clinic, Mayo Medical School, Rochester, Minnesota, USA

    David R. Holmes Jr. MD (Professor of Medicine, Director, Consultant) (Professor of Medicine, Director, Consultant)

  2. Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Mayo Medical School, Rochester, Minnesota, USA

    Verghese Mathew MD (Assistant Professor of Medicine, Consultant) (Assistant Professor of Medicine, Consultant)

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Barsness, G.W., Bresnahan, J.F. (2003). Specific Lesion Subsets. In: Holmes, D.R., Mathew, V. (eds) Atlas of Interventional Cardiology. Current Medicine Group, London. https://doi.org/10.1007/978-1-4613-1091-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1091-4_10

  • Publisher Name: Current Medicine Group, London

  • Print ISBN: 978-1-4757-0808-0

  • Online ISBN: 978-1-4613-1091-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation